Neurocrine Biosciences Stock Price on December 18, 2024
| NBIX Stock | USD 136.69 3.64 2.74% |
Below is the normalized historical share price chart for Neurocrine Biosciences extending back to May 23, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurocrine Biosciences stands at 136.69, as last reported on the 18th of December 2024, with the highest price reaching 137.24 and the lowest price hitting 132.10 during the day.
If you're considering investing in Neurocrine Stock, it is important to understand the factors that can impact its price. Neurocrine Biosciences appears to be very steady, given 3 months investment horizon. Neurocrine Biosciences has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Neurocrine Biosciences, which you can use to evaluate the volatility of the firm. Please exercise Neurocrine Biosciences' Downside Deviation of 1.48, risk adjusted performance of 0.0819, and Mean Deviation of 1.23 to check out if our risk estimates are consistent with your expectations.
At this time, Neurocrine Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 61.8 M in 2024. . At this time, Neurocrine Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 6.13 in 2024, whereas Price To Sales Ratio is likely to drop 6.48 in 2024. Neurocrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 1996 | 200 Day MA 132.9728 | 50 Day MA 121.8756 | Beta 0.353 |
Neurocrine |
Sharpe Ratio = 0.1216
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NBIX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.78 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Neurocrine Biosciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurocrine Biosciences by adding it to a well-diversified portfolio.
Price Book 5.0901 | Enterprise Value Ebitda 23.1388 | Price Sales 6.1706 | Shares Float 100.1 M | Wall Street Target Price 163.6919 |
Related Headline
Ironwood Pharmaceuticals Headline on 17th of December 2024
Ironwood Pharmaceuticals SWOT analysis apraglutides promise ... by investing.com
Ironwood Pharmaceuticals SWOT analysis apraglutides promise lifts stock outlook
Neurocrine Biosciences Valuation on December 18, 2024
It is possible to determine the worth of Neurocrine Biosciences on a given historical date. On December 18, 2024 Neurocrine was worth 132.51 at the beginning of the trading date compared to the closed value of 136.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neurocrine Biosciences stock. Still, in general, we apply an absolute valuation method to find Neurocrine Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neurocrine Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neurocrine Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 127.67 | 134.81 | 127.35 | 133.05 | 1,651,133 | |
12/17/2024 | 132.51 | 137.24 | 132.10 | 136.69 | 1,578,232 |
| Backtest Neurocrine Biosciences | | | Neurocrine Biosciences History | | | Neurocrine Biosciences Valuation | Previous |
Neurocrine Biosciences Trading Date Momentum on December 18, 2024
| On December 17 2024 Neurocrine Biosciences was traded for 136.69 at the closing time. The top price for the day was 137.24 and the lowest listed price was 132.10 . The trading volume for the day was 1.6 M. The trading history from December 17, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.06% . |
Neurocrine Biosciences Fundamentals Correlations and Trends
By evaluating Neurocrine Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neurocrine Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neurocrine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neurocrine Biosciences Stock history
Neurocrine Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurocrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurocrine Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurocrine Biosciences stock prices may prove useful in developing a viable investing in Neurocrine Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 101 M | 61.8 M | |
| Net Income Applicable To Common Shares | 177.7 M | 186.6 M |
Neurocrine Biosciences Quarterly Net Working Capital |
|
Neurocrine Biosciences Stock Technical Analysis
Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neurocrine Biosciences Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Neurocrine Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neurocrine Biosciences December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Neurocrine Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurocrine Biosciences shares will generate the highest return on investment. By undertsting and applying Neurocrine Biosciences stock market strength indicators, traders can identify Neurocrine Biosciences entry and exit signals to maximize returns
Neurocrine Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neurocrine Biosciences' price direction in advance. Along with the technical and fundamental analysis of Neurocrine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurocrine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0819 | |||
| Jensen Alpha | 0.1149 | |||
| Total Risk Alpha | 0.0343 | |||
| Sortino Ratio | 0.0787 | |||
| Treynor Ratio | 0.1692 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.